National Bank Of Canada Pfizer Inc Transaction History

National Bank Of Canada

$62.9 Billion
Q2 2024

A detailed history of National Bank Of Canada transactions in Pfizer Inc stock. As of the latest transaction made, National Bank Of Canada holds 10,529,077 shares of PFE stock, worth $289 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares

10,529,077

Previous 12,936,678 18.61%

Holding current value

$289 Million

Previous $359 Million 17.94%

% of portfolio

0.47%

Previous 0.62%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	SELL	$25.26 - $29.6 $60.8 Million - $71.3 Million	-2,407,601 Reduced 18.61%	10,529,077 $295 Million
Q1 2024 May 13, 2024	BUY	$25.89 - $29.73 $137 Million - $157 Million	5,286,849 Added 69.11%	12,936,678 $359 Million
Q4 2023 Feb 06, 2024	SELL	$26.13 - $33.94 $149 Million - $193 Million	-5,689,347 Reduced 42.65%	7,649,829 $220 Million
Q3 2023 Oct 10, 2023	BUY	$32.09 - $37.51 $165 Million - $193 Million	5,132,386 Added 62.54%	13,339,176 $442 Million
Q2 2023 Jul 26, 2023	BUY	$36.12 - $41.79 $241 Million - $279 Million	6,676,325 Added 436.23%	8,206,790 $301 Million
Q1 2023 Apr 12, 2023	SELL	$39.39 - $51.28 $82.9 Million - $108 Million	-2,105,480 Reduced 57.91%	1,530,465 $62.4 Million
Q4 2022 Jan 24, 2023	BUY	$41.75 - $54.5 $77.1 Million - $101 Million	1,847,433 Added 103.29%	3,635,945 $0
Q3 2022 Oct 13, 2022	BUY	$43.76 - $53.42 $10.1 Million - $12.3 Million	230,867 Added 14.82%	1,788,512 $78.3 Million
Q2 2022 Jul 28, 2022	BUY	$46.53 - $55.17 $11.3 Million - $13.4 Million	242,059 Added 18.4%	1,557,645 $81.7 Million
Q1 2022 May 05, 2022	SELL	$45.75 - $56.69 $98.8 Million - $122 Million	-2,160,269 Reduced 62.15%	1,315,586 $67.8 Million
Q4 2021 Jan 24, 2022	BUY	$41.32 - $61.25 $144 Million - $213 Million	3,475,855 New	3,475,855 $205 Million

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.

Account

National Bank Of Canada Pfizer Inc Transaction History